Peter O'Dwyer

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Celgene
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Incyte
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Lilly/Imclone
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    array
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    h3biomedicine
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Taiho
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Minneamrata
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    pharmacyclics
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    abbvie
    Date added:
    09/20/2023
    Date updated:
    09/20/2023

Pages

Return to 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes